Aims/hypothesis O-GlcNAcylation is characterised by the addition of N-acetylglucosamine to various proteins by O-GlcNAc transferase (OGT) and serves in sensing intracellular nutrients by modulating various cellular processes. Although it has been speculated that O-GlcNAcylation is associated with glucose metabolism, its exact role in whole body glucose metabolism has not been fully elucidated. Here, we investigated whether loss of O-GlcNAcylation globally and in specific organs affected glucose metabolism in mammals under physiological conditions. Methods Tamoxifen-inducible global Ogt-knockout (Ogt-KO) mice were generated by crossbreeding Ogt-flox mice with R26-Cre-ER T2 mice. Liver, skeletal muscle, adipose tissue and pancreatic beta cell-specific Ogt-KO mice were generated by crossbreeding Ogt-flox mice with Alb-Cre, Mlc1f-Cre, Adipoq-Cre and Pdx1 PB -CreER™ mice, respectively. Glucose metabolism was evaluated by i.p. glucose and insulin tolerance tests. Results Tamoxifen-inducible global Ogt-KO mice exhibited a lethal phenotype from 4 weeks post injection, suggesting that O-GlcNAcylation is essential for survival in adult mice. Tissue-specific Ogt deletion from insulin-sensitive organs, including liver, skeletal muscle and adipose tissue, had little impact on glucose metabolism under physiological conditions. However, pancreatic beta cell-specific Ogt-KO mice displayed transient hypoglycaemia (Ogt-flox 5.46 ± 0.41 vs Ogt-βKO 3.88 ± 0.26 mmol/l) associated with about twofold higher insulin secretion and accelerated adiposity, followed by subsequent hyperglycaemia (Ogt-flox 6.34 ± 0.32 vs Ogt-βKO 26.4 ± 2.37 mmol/l) with insulin depletion accompanied by beta cell apoptosis. Conclusions/interpretation These findings suggest that OGlcNAcylation has little effect on glucose metabolism in insulin-sensitive tissues but plays a crucial role in pancreatic beta cell function and survival under physiological conditions. Our results provide novel insight into O-GlcNAc biology and physiology in glucose metabolism.
Introduction
Post-translational modifications to intracellular proteins regulate a variety of physiological cellular functions. Growing evidence indicates that dysfunction of post-translational modifications, including phosphorylation, ubiquitination and acetylation, disrupts cellular homeostasis and is strongly associated with the pathogenesis of numerous diseases, including metabolic disorders [1] [2] [3] . Thus, elucidation of the relationship between post-translational modifications and cellular physiology may be a first step to better understand disease pathogenesis and provide insight into the development of novel therapeutics.
O-GlcNAcylation has been analysed as an important regulator of glucose metabolism [4] [5] [6] . In a branch of the glycolytic pathway, fructose-6-phosphate is converted into uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) through multiple enzymes in the hexosamine biosynthetic pathway. In this process, not only glucose but also glutamine and acetyl-CoA are integrated to form UDP-GlcNAc. O-GlcNAc transferase (OGT) is essential for O-GlcNAcylation and attaches O-GlcNAc to proteins at specific serine or threonine residues [7] . Thus, O-GlcNAcylation has recently received remarkable attention as 'an intracellular nutrient sensor' that can regulate diverse cellular processes in response to nutritional status [8] .
O-GlcNAcylation is conserved throughout species. OGlcNAc modification in Caenorhabditis elegans plays an important role in longevity, stress and immunity [9] . In drosophila, knockdown of Ogt reduced IGF homologue expression, thereby affecting organism growth and glucose metabolism [10] . These observations indicate a potential role for OGlcNAcylation in glucose metabolism in mammals. Indeed, previous studies in cultured cells have demonstrated that OGlcNAcylation is involved in glucose metabolism in the liver [11] , skeletal muscle [12] and adipose tissues [13] , and accelerates insulin secretion in pancreatic beta cells [14] . However, little is known about the physiological roles of this posttranslational modification in glucose metabolism in vivo because congenital Ogt-knockout (KO) mice are embryonic lethal [15] .
In this study, to reveal the physiological role of OGlcNAcylation in glucose metabolism in living mice, tamoxifen (TM)-inducible global Ogt-KO mice were analysed. In addition, mice lacking Ogt in glucose metabolism-related tissues, including the liver, skeletal muscle, adipose tissues and pancreatic beta cells, were analysed.
Methods
Animal experiments All animal handling and experimentation were conducted according to the guidelines of the Islet isolation study Primary mouse islets from Ogt-flox and Ogt-βKO mice were isolated by collagenase digestion as described previously with slight modifications [21] .
Blood analysis Blood glucose concentrations were measured with GDH-PQQ glucose test strips (Glutest Sensor, Sanwa Kagaku, Nagoya, Japan). Plasma insulin and glucagon levels were measured by ELISA (Morinaga, Tokyo, Japan, and Mercodia, Uppsala, Sweden).
Insulin and glucose tolerance tests Mice were i.p. injected with 0.5 U/kg insulin or 1 g/kg glucose after fasting for 6-8 h.
Blood glucose levels were determined 15, 30, 60, 90 and 120 min after injection.
Histological analyses Fixed specimens embedded in paraffin were sectioned (3 μm thickness). Antibodies to O-linked Nacetylglucosamine (1:200, ab2739, Abcam, Cambridge, UK), insulin (1:500, ab7842, Abcam) and Ki67 (1:100, ab16667, Abcam) were used. Transmission electron microscopic analysis was performed with the Hitachi H-7500 (Hitachi, Tokyo, Japan). Cell apoptosis was analysed using the TACS2 TdT In Situ Apoptosis Detection Kit (Trevigen, Gaithersburg, MD, USA).
Total RNA preparation and qRT-PCR analysis Total RNA was extracted from tissues using the RNeasy Kit (Qiagen, Valencia, CA, USA). cDNA was synthesised using reverse transcription reagents (Takara Bio, Otsu, Japan 
Results
Ogt deletion in adult mice resulted in a lethal phenotype accompanied by body weight loss and hypoglycaemia We first clarified the physiological role of O-GlcNAcylation in glucose metabolism in adult mice. Congenital global Ogt deletion is embryonic lethal, indicating that Ogt is critical for development in mice [15] . TM-inducible global Ogt-KO mice were generated by crossbreeding Ogt-flox female mice [15] with R26-Cre-ER T2 male mice [16] (Fig. 1a) . At 10 weeks of age, Ogt deletion was induced by i.p. TM injection (Fig. 1a) . Immunohistochemical analysis demonstrated that OGlcNAcylation was present in both the nucleus and cytosol of liver, skeletal muscle, adipose tissue cells and particularly pancreatic islets, and O-GlcNAcylation was absent from these tissues in Ogt-KO mice (Fig. 1b) . In addition, western blot analysis revealed decreases in Ogt and O-GlcNAcylation (RL2) levels in other tissues with varying magnitudes (ESM Fig. 1a) . Following TM injection, Ogt-KO mice gradually lost weight accompanied by loss of body fat mass (Fig. 1c, d) . Moreover, blood glucose and plasma insulin levels also gradually decreased (Fig. 1e, f) . At 4 weeks after TM injection, Ogt-KO mice exhibited hypothermia and severe malnutrition, although their food intake did not significantly decrease (Fig. 1g , h, ESM Table 2 ). Finally, Ogt-KO mice began to die, and only 20% of Ogt-KO mice survived until 6 weeks after TM injection (Fig. 1i) . As a result, we were unable to analyse glucose metabolism in these mice. These data indicate that O-GlcNAcylation is essential not only for embryonic development but also for survival in adult mice.
To examine the role of O-GlcNAcylation in glucose metabolism, we generated tissue-specific Ogt-KO mice and analysed the role of O-GlcNAcylation in each tissue.
Insulin-sensitive tissue-specific Ogt deletion had no major effects on glucose metabolism We generated tissue-specific Ogt-KO mice for insulin-sensitive tissues, including liver (Ogt-LKO), skeletal muscle (Ogt-MKO) and adipose tissue (Ogt-FKO), by crossbreeding Ogt-flox mice with Alb-Cre [17] , Mlc1f-Cre [18] and Adipoq-Cre mice [19] , respectively (ESM Fig. 2a ). Western blot analysis indicated significant decreases in OGT protein levels and O-GlcNAcylation in these tissues (ESM Fig. 2b, c) . Ogt-LKO, Ogt-MKO and Ogt-FKO mice grew normally and displayed no significant changes in fasting glucose levels compared with those of control littermates at 10 weeks of age ( Fig. 2a-f) . Furthermore, insulin-sensitive tissue-specific Ogt-KO mice exhibited normal glucose levels during an IPGTT. Additionally, they displayed little difference in insulin sensitivity by insulin tolerance test compared with control littermates (Fig. 2g-l) . Since Ogt knockdown in insulin-sensitive tissues had little impact on glucose metabolism under physiological conditions, we evaluated the role of O-GlcNAcylation in pancreatic beta cells.
Pancreatic beta cell-specific Ogt-KO mice displayed biphasic changes in glucose metabolism To evaluate the role of Ogt in glucose metabolism in pancreatic beta cells, we generated TM-inducible beta cell-specific Ogt-KO mice (Ogt-βKO) by crossbreeding female Ogt-flox mice with male Pdx1-CreER™ mice [20] (Fig. 3a) . At 10 weeks of age, TM was injected i.p. in both groups of mice. Western blot and immunohistochemical analyses indicated that OGT protein levels and protein O-GlcNAcylation were markedly diminished in pancreatic beta cells from Ogt-βKO mice ( Fig. 3b-e) . Interestingly, in Ogt-βKO mice body weight was markedly increased 6 weeks after TM injection because of mild hyperphagia but subsequently decreased from 8 weeks postinjection ( Fig. 3f, ESM Fig. 3a) . In contrast, Ogt-βKO blood glucose levels transiently decreased at 5-6 weeks and then dramatically increased after 8 weeks post-injection (Fig. 3g) . Finally, Ogt-βKO mice displayed severe hyperglycaemia at 10 weeks post-injection (Fig. 3g) . Consistent with temporal changes in glucose levels, plasma insulin levels in Ogt-βKO mice transiently increased 5-7 weeks post-injection and were eventually depleted at 10 weeks (Fig. 3h ). IPGTT were performed every week between 5 and 8 weeks post-injection. The results indicated a biphasic change in glucose tolerance, with a hypoglycaemic state occurring at 5-6 weeks post-injection (early phase) and a hyperglycaemic state occurring at 7-8 weeks post-injection (late phase) (Fig. 3i-m) .
Transient hyperinsulinaemia improved glucose tolerance and accelerated adiposity during the early phase Ogt-βKO mice displayed lower glucose levels during the early phase but hyperglycaemia during the late phase (Fig. 3g) . During the early phase, we observed significant increases in body weight in Ogt-βKO mice (Figs 3f, 4a) . Furthermore, marked steatosis and increased adiposity in Ogt-βKO mice could be explained by hyperphagia resulting from enhanced insulin secretion followed by hypoglycaemia (Fig. 4b, c) . In fact, Ogt-βKO mice displayed increased insulin secretion in response to a glucose challenge prior to weight gain (Fig. 4d, e) . Histological analysis demonstrated that islet area, size and Ki67 positive cells were increased in Ogt-βKO mice (Fig. 4f-i ), but no significant changes were detected in pancreatic islets by immunohistochemistry for insulin (Fig. 4j, k) . Moreover, insulin secretion and content per isolated islet was increased in Ogt-βKO mice (Fig. 4l, m) and was accompanied by increased expression of the gene encoding insulin (Ins2) (Fig. 4n) . These findings suggest that loss of OGlcNAcylation in pancreatic beta cells may have lowered glucose levels during the early phase by increasing insulin secretion and enhancing islet growth. Taken together, in the early phase, deletion of Ogt-mediated O-GlcNAcylation resulted in accelerated insulin secretion in vivo, accompanied by increased insulin expression and islet growth, resulting in enhanced insulin-induced adiposity in vivo.
Depletion of Ogt resulted in hypoinsulinaemia because of beta cell apoptosis During the late phase, a significant increase in blood glucose levels was accompanied by depleted insulin secretion (Figs 3g, h, 5a, b) . Histological analysis demonstrated decreased islet number and size (Fig. 5c-e) . Furthermore, insulin-positive area was significantly decreased in Ogt-βKO mice compared with control mice (Fig. 5f, g ). Transmission electron microscopic analysis revealed fewer insulin granules with abnormal morphology (Fig. 5h) . 
Body temperature (°C) Similarly, insulin and beta cell-related gene expression levels were significantly reduced (Fig. 5i) . TUNEL staining indicated a significant increase in apoptotic cells in Ogt-βKO mouse islets (Fig. 5j, k) . These findings suggest that Ogt-mediated OGlcNAcylation is essential for beta cell survival.
Discussion
In this study, we comprehensively evaluated the role of OGlcNAcylation in glucose metabolism in multiple tissues using tissue-specific Ogt-KO mice under physiological conditions. Because congenital Ogt gene deletion in mice caused embryonic lethality [15] , little was known about the role of OGlcNAcylation in systemic glucose metabolism. In this study, for the first time, we generated TM-inducible systemic Ogt-KO mice, which allowed us to analyse the role of OGlcNAcylation in glucose metabolism in adult mammals. Ogt-KO mice displayed gradual body weight loss (Fig. 1c) . Furthermore, Ogt-KO mouse mortality rates increased dramatically 4 weeks after TM injection (Fig. 1i) . These results suggest that O-GlcNAcylation is essential not only for organ development in embryos but also for survival in adult mice.
Next we created insulin-sensitive tissue-specific Ogt-KO mice. Ogt knockdown in liver, skeletal muscle and adipose tissue had minimal impact on glucose homeostasis under physiological conditions (Fig. 2) . In contrast to our results, previous studies have reported that excess O-GlcNAcylation in mice led to insulin resistance [22] [23] [24] . Collectively, these results suggest that gain-of-function of O-GlcNAcylation in insulin-sensitive organs is associated with the pathogenesis of insulin resistance, whereas loss-of-function does not impact glucose metabolism under physiological conditions. Further examination is necessary to investigate the loss of OGlcNAcylation during various pathological conditions (e.g. diabetes), starvation and exercise.
A prominent phenotype was observed in Ogt-βKO mice. Acquired Ogt deletion revealed a unique phenotype. Specifically, mice displayed reduced glucose levels accompanied by enhanced insulin secretion during the early phase and hyperglycaemia accompanied by insulin depletion during the late phase (Fig. 3h-k) . A recent study reported that loss of Ogt in pancreatic beta cells induced severe hyperglycaemia and insulin depletion, potentially because of endoplasmic reticulum (ER) stress, using a similar mouse model [25] . Their results were consistent with the late phase phenotype of our study, and increased levels of ER stress markers, such as Chop Change from baseline (%)
Time ( and Bip, were also observed in our model. Additionally, our study revealed that Ogt deletion transiently promoted insulin secretion and beta cell growth and subsequently increased adiposity during the early phase (Fig. 3) . These results suggest that O-GlcNAcylation regulates not only beta cell survival but also insulin secretion and beta cell capacity under physiological conditions. Two unresolved issues remain. The first issue is a technical limitation. A recent study reported that Pdx1 PB -CreER™ mice also express Cre in pancreatic alpha cells and the hypothalamus [26] . In our model, there were no significant differences in plasma glucagon levels between Ogt-βKO mice and control littermates, suggesting a limited effect of Ogt deletion on glucagon secretion (ESM Fig. 3b ). In the hypothalamus, a recent report demonstrated that loss of O-GlcNAcylation in paraventricular nucleus neurons resulted in a rapid obese phenotype in which food intake more than doubled within 2 weeks following Cre induction [27] . Our mouse model also displayed transient obesity with mild hyperphagia. However, the increase in food intake was modest, and body weight gain was delayed compared with mice lacking O-GlcNAcylation in paraventricular nucleus neurons (ESM Fig. 3a) . Furthermore, we observed hyperinsulinaemia and hypoglycaemia in the mice 5-6 weeks after Ogt deletion. Hypoglycaemia induced by hyperinsulinaemia is often accompanied by hyperphagia to alleviate hypoglycaemia. Therefore, it induces weight gain, which is often observed in people with type 2 diabetes receiving insulin treatment [28, 29] . Thus, we speculate that body weight gain between 5 and 8 weeks post-deletion is a secondary effect resulting from hypoglycaemia rather than an effect in the hypothalamus. Further investigation will be necessary to confirm the direct effects in pancreatic beta cells.
Second, the cause of death in the global Ogt-KO mouse is unclear. Although Ogt-βKO mice exhibited severe hyperglycaemia, none of the tissue-specific KO mice displayed the mortality rates observed in the global Ogt-KO mouse. One recent study demonstrated that heartspecific Ogt deletion was also lethal because of heart failure [30] . However, we did not detect elevated Bnp (also known as Nppb) mRNA expression in Ogt-KO mice (ESM Fig. 1b) . Interestingly, although food intake did not decrease, severe malnutrition and hypometabolism were observed before death (ESM Table 2 ). Thus, we speculate that heart failure was not responsible for increased mortality rates in this model; however, malabsorption of nutrients could be the cause of the increased mortality rates. In addition, our results from global and beta cell-specific Ogt-KO mice clearly indicate that OGlcNAcylation inhibition is inappropriate for the treatment of insulin resistance and diabetes complications because of its harmful effects. A recent proteomics approach revealed over 1000 OGT targets in mammalian cells [31] . Identification of the specific O-GlcNAcylated protein may provide a novel therapeutic strategy for the treatment of diabetes mellitus.
In conclusion, O-GlcNAcylation plays a pivotal role in glucose and cellular homeostasis in adult mammals. In addition, O-GlcNAcylation in insulin-sensitive tissues does not substantially impact glucose metabolism under physiological conditions, whereas O-GlcNAcylation in pancreatic beta cells has multiple effects on insulin secretion and beta cell homeostasis. Glucose (mmol/l) Duality of interest The authors declare that there is no duality of interest associated with this manuscript. 
